Heart failure with reduced ejection fraction due to dilated cardiomyopathy in a patient with hypocalcemic cardiomyopathy, secondary to primary hypoparathyroidism.
SGLT2 inhibitors reduce the risk of incident gout and gout flares in patients with type 2 diabetes and offer cardiovascular benefits, compared with sulfonylureas.
Results show ninerafaxstat is well tolerated by patients with nonobstructive hypertrophic cardiomyopathy, with early signs of improvement in exercise capacity.
People with connective tissue disease-related interstitial lung disease have an increased risk for developing venous thromboembolisms. What risk factors do clinicians need to be aware of?
The delayed titration of guideline-directed medical therapy is complex and often results in poor prognosis for heart failure patients. Are you using GDMT in the most effective way?
An ECG displaying "shark fin"-like characteristics in V3-V6 was seen in a patient with recent history of intestinal ischemia. Can you predict the final diagnosis?
The risks of ischemic and hemorrhagicstroke and poor neurological outcomes after stroke are increased in people with type 2 diabetes. Explore how to manage the hyperacute stroke stage and prevent CV disease.
Managing patients with acute or chronic HFpEF and concurrent hypertension is difficult. Make sure you're confident prescribing the optimal drug combination.
Employing strategies that earn points or a small amount of money motivates people at high risk of heart disease or stroke to walk more each day than they would otherwise.
New trial results show routine use of a microaxial flow pump reduces all-cause mortality risk among patients with STEMI complicated by cardiogenic shock.
Do you know the symptoms of a double chambered right ventricle in a child? Discover how to recognise, diagnose, and treat such cases in your clinic with this insightful case report.
STEP-HFpEF trial findings indicate that weekly semaglutide improves heart failure symptoms, physical limitations, and body weight in people with obesity-related heart failure and type 2 diabetes.
The Improving Diabetes Steering Committee outlines the place, value, and advantages of SGLT2 inhibitors in the treatment of type 2 diabetes. With user-friendly tools to support their use.
Primary cardiac angiosarcomas are very aggressive tumors that often present after metastatic spread. In this case, initial presentation with chest pain rapidly progressed to multiple solid tumors.
SAMS are the main reason statins are discontinued, but they range in severity and persistence. Learn about self-limited and autoimmune statin myopathy, the factors that impact them, and available treatment strategies.
